Retrospective multicenter comparative study of the efficacy and safety between R-DHAC and R-DHAOx in diffuse large B-cell lymphoma or transformed follicular or marginal zone B lymphoma into aggressive lymphoma, as a second-line treatment

Click to increase image sizeClick to decrease image size Author contributionsLF, ED, FT, and JC designed the research and/or analyzed the data. LF, ET, HG, EM, PS, OT, JOB, ASM, MS, EC, DG, and JC collected the data. LF, ED, and JC wrote the paper. All the authors approved the final manuscript.Disclosure statementNo potential conflict of interest was reported by the author(s).Additional informationFundingThe author(s) reported there is no funding associated with the work featured in this article.